• Cell Counting Kit-8 (CCK-8) Plus: Precise WST-8 Cell Assays

  2026-06-10

  Cell Counting Kit-8 (CCK-8) Plus provides a sensitive and rapid approach for quantifying cell proliferation and cytotoxicity using a WST-8 tetrazolium salt assay. It is best suited for researchers needing reproducible cell viability data in drug screening, cytotoxicity, and proliferation workflows. It should not be used for direct cell counting in the absence of metabolic activity or for endpoint-measurements incompatible with colorimetric detection.

• ASMase Drives Mitochondrial Ca2+ Overload in Diabetic Cardio

  2026-06-09

  Wei et al. reveal how acid sphingomyelinase (ASMase) promotes diabetic cardiomyopathy by enhancing mitochondria-associated ER membrane (MAM) formation and MICU1-mediated mitochondrial Ca2+ overload, triggering cardiac apoptosis. This mechanistic insight positions the ASMase–MICU1 axis as a promising therapeutic target for diabetic heart disease.

• SNS-032 (BMS-387032): Precision CDK Inhibition in Cancer and

  2026-06-09

  Explore the scientific depth of SNS-032 (BMS-387032), a potent CDK2/7/9 inhibitor, and its dual relevance in cancer research and host-pathogen studies. This article uniquely dissects how mechanistic insights guide protocol design and translational applications.

• IGFBP2–THBS1 Axis in GH Therapy: Mechanisms in ISS Bone Grow

  2026-06-08

  This study reveals that recombinant human growth hormone (GH) therapy promotes bone growth in children with idiopathic short stature (ISS) by activating the IGF-1 pathway through IGFBP2-mediated inhibition of THBS1. These findings clarify the molecular cascade underlying GH efficacy and identify the IGFBP2–THBS1 interaction as a promising target for optimizing ISS treatment.

• Distinct Vascular Effects of JAK Inhibitors in Endothelial I

  2026-06-08

  This study systematically compares the impact of six approved JAK inhibitors—including tofacitinib citrate—on endothelial cell responses to inflammatory cytokines. The findings reveal nuanced differences in cytokine suppression, adhesion molecule expression, and cytotoxicity, offering mechanistic insights relevant to cardiovascular safety in immune regulation research.

• EdU Imaging Kits: Precision DNA Synthesis Measurement in RCC

  2026-06-07

  EdU Imaging Kits (HF488) enable high-sensitivity, non-destructive measurement of cell proliferation, streamlining workflows for translational oncology and drug development. Leveraging click chemistry, these kits deliver robust, quantitative insights for DNA synthesis analysis—outperforming traditional BrdU assays in both flexibility and data quality.

• Chlorin e6 (Ce6): Bridging Anticancer and Antibacterial PDT

  2026-06-06

  Explore the dual potential of Chlorin e6 as a Ce6 photosensitizer in advanced photodynamic therapy. This article uniquely examines its mechanistic versatility, latest biomaterial integrations, and real-world protocol insights for cancer and resistant infection research.

• Flavopiridol (L868275): Advanced Cell Cycle Arrest Workflows

  2026-06-05

  Flavopiridol (L868275) offers researchers a powerful cell cycle arrest agent for dissecting CDK-dependent pathways and modeling cancer phenotypes. This article delivers actionable protocols, cross-domain insights, and troubleshooting tactics, optimizing its use in translational research and tumor model studies.

• Isradipine (Dynacirc): Precision Strategies for Calcium Chan

  2026-06-05

  Explore Isradipine’s unique precision as a calcium channel blocker for research, with advanced insights into channel selectivity, neuroprotection, and vascular smooth muscle relaxation. This article delivers actionable guidance and protocol nuance for scientists seeking more than standard application advice.

• COX-2 Pathway’s Dual Role in Muscle Injury and Revasculariza

  2026-06-04

  This study reveals a time-dependent function of the cyclooxygenase-2 (COX-2) pathway in skeletal muscle injury induced by Bothrops asper venom. Early COX-2 inhibition exacerbates ischemia, while delayed inhibition promotes angiogenesis and tissue repair, highlighting key windows for intervention in muscle regeneration research.

• Engineered KR-12 Peptides: Expanding Antimicrobial & Immunom

  2026-06-04

  The reference review details how KR-12, the minimal active fragment of human cathelicidin LL-37, has been structurally engineered to enhance antimicrobial, anti-biofilm, and immunomodulatory properties. Through a combination of rational design strategies and validation in preclinical models, KR-12 variants demonstrate potential for combating drug-resistant pathogens and modulating host responses.

• Cy5-UTP: Precision RNA Labeling for Advanced lncRNA Research

  2026-06-03

  Explore how Cy5-UTP (Cyanine 5-uridine triphosphate) enables precise, sensitive RNA labeling for advanced in vitro transcription workflows, with unique insights into its role in lncRNA functional studies. Discover protocol guidance, practical assay implications, and scientific depth not found in other resources.

• Poly(I:C): Distinct Mechanisms and Next-Gen Immune Modeling

  2026-06-03

  Explore how Poly(I:C), a synthetic double-stranded RNA analog, enables precision immune response modeling and advances dendritic cell maturation research. This article offers a uniquely mechanistic and translational analysis, bridging immunology, cell death, and practical assay design.

• Iron, KDM4D, and the PI3K-Akt-Foxo1 Axis in MSC Activation a

  2026-06-02

  This study uncovers how iron-dependent KDM4D activity modulates the quiescence and activation of mesenchymal stem cells (MSCs) via the PI3K-Akt-Foxo1 pathway, impacting bone remodeling. The findings offer mechanistic insight into the epigenetic regulation of MSCs in iron deficiency and suggest potential intervention points for metabolic bone disorders.

• Berberine Hydrochloride Expands Tuft Cells to Counter Bone L

  2026-06-02

  A recent study demonstrates that berberine hydrochloride mitigates estrogen deficiency-associated bone loss by inducing intestinal tuft cell expansion through a butyrate-GPR41 signaling pathway. This novel mechanism extends the therapeutic potential of berberine and provides new insight into the gut-bone axis for postmenopausal osteoporosis research.

449 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page